Information Provided By:
Fly News Breaks for June 6, 2019
MNTA, AMPH
Jun 6, 2019 | 14:08 EDT
Wells Fargo analyst David Maris maintained an Outperform rating and $29 price target on Amphastar (AMPH) after finding "several recently filed legal motions related to the ongoing legal dispute between Amphastar and Sandoz/Momenta." Maris believes, based on these filings, that Amphastar has reached a resolution in its patent and anti-trust legal dispute with Momenta (MNTA) and Sandoz regarding enoxaparin.
News For AMPH;MNTA From the Last 2 Days
There are no results for your query AMPH;MNTA